Eicosapentaenoic acid and/or aspirin for preventing colorectal adenomas during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme: the seAFOod RCT (2019)
Attributed to:
A randomised controlled trial of eicosapentaenoic acid (EPA) and/or aspirin for colorectal adenoma (or polyp) preve
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3310/eme06040
PubMed Identifier: 31268645
Publication URI: http://europepmc.org/abstract/MED/31268645
Type: Journal Article/Review
Parent Publication: Efficacy and Mechanism Evaluation
Issue: 4